Phase i study of a modified regimen of 90yttrium-ibritumomab tiuxetan for relapsed or refractory follicular or transformed cd20+ non-hodgkin lymphoma

Christos Vaklavas, Ruby F. Meredith, Sui Shen, Susan J. Knox, Ivana N. Micallef, Jatin J. Shah, Albert F. Lobuglio, Andres Forero-Torres

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'Phase i study of a modified regimen of <sup>90</sup>yttrium-ibritumomab tiuxetan for relapsed or refractory follicular or transformed cd20+ non-hodgkin lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences